News Analysis

Most Recent

- or is it the other way around?

By | December 14, 2000

Donald Kennedy.


HOUSTON A variety of motives are behind several recent drug company announcements of donations of HIV/AIDS drugs to African countries. Certainly, something needs to be done to control existing cases of HIV/AIDS, in addition to the lifestyle changes that would reduce the number of new AIDS cases. By the end of this year, 36.1 million people will be living with HIV or AIDS, according to the Joint United Nations Program on HIV/AIDS (UNAIDS) and the World Health Organization (WHO).WHO and UNAIDS res


Why did the chicken cross the DNA?

By | December 6, 2000

Advances in transgenics and drug production are foreseen using chicken eggs, says the Roslin Institute. But why chickens?


Banking on genes

By | December 4, 2000

Various high-profile genetic projects around the world are pushing the barriers of research. But are they trespassing on human rights?


Drug metabolites can now be patented

By | November 29, 2000

HOUSTON Bristol-Myers Squibb Company unveiled both a scientific achievement and a patent strategy that, if used by other drug companies, could delay introduction of cheaper generic versions of hundreds of patented drugs. Typically, after patents expire and generic versions of a drug become available, most drugs lose up to 80% of sales during the first year they face generic competition, according to Barbara Ryan, a drug industry analyst with Deutsche Banc Alex Brown. US patents on drugs with sal


Potential AIDS epidemic in Eastern Europe

By | November 29, 2000

Experts fear that Eastern Europe could experience an AIDS epidemic similar to that seen in Africa.


Online prescription drugs

November 23, 2000

A new website from the US Food and Drug Administration (FDA) warns that many online pharmacies provide legitimate prescription services but that some questionable sites may make purchasing medicines online risky.On its website dedicated to this topic, the FDA highlights some of the problems associated with purchasing prescriptions online. These include sub-standard products; little or no quality control; possibility of an incorrect diagnosis by sites that inappropriately diagnose and prescribe o


Zebrafish genome to be sequenced

By | November 23, 2000

The genome of the zebrafish is to be sequenced at the Wellcome Trust's Sanger Centre near Cambridge, UK.


110m into post-genomic research

By | November 22, 2000

500,000 people will help research councils to solve post-genomic puzzles.


Children's parents sue hospital over genetics patent

By | November 22, 2000

Families of children suffering a degenerative brain disease are suing the hospital and researchers who used their children's blood and tissue to identify and patent the gene responsible for the disorder.


Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham